JP2014529073A5 - - Google Patents

Download PDF

Info

Publication number
JP2014529073A5
JP2014529073A5 JP2014527328A JP2014527328A JP2014529073A5 JP 2014529073 A5 JP2014529073 A5 JP 2014529073A5 JP 2014527328 A JP2014527328 A JP 2014527328A JP 2014527328 A JP2014527328 A JP 2014527328A JP 2014529073 A5 JP2014529073 A5 JP 2014529073A5
Authority
JP
Japan
Prior art keywords
hours
subject
serum creatinine
correlating
future
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014527328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014529073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/052298 external-priority patent/WO2013043310A1/en
Publication of JP2014529073A publication Critical patent/JP2014529073A/ja
Publication of JP2014529073A5 publication Critical patent/JP2014529073A5/ja
Pending legal-status Critical Current

Links

JP2014527328A 2011-08-26 2012-08-24 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 Pending JP2014529073A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161528003P 2011-08-26 2011-08-26
US201161528000P 2011-08-26 2011-08-26
US61/528,000 2011-08-26
US61/528,003 2011-08-26
PCT/US2012/052298 WO2013043310A1 (en) 2011-08-26 2012-08-24 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016204848A Division JP2017032586A (ja) 2011-08-26 2016-10-19 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物

Publications (2)

Publication Number Publication Date
JP2014529073A JP2014529073A (ja) 2014-10-30
JP2014529073A5 true JP2014529073A5 (enExample) 2015-08-20

Family

ID=47914751

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014527328A Pending JP2014529073A (ja) 2011-08-26 2012-08-24 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
JP2016204848A Pending JP2017032586A (ja) 2011-08-26 2016-10-19 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016204848A Pending JP2017032586A (ja) 2011-08-26 2016-10-19 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物

Country Status (16)

Country Link
US (2) US9459261B2 (enExample)
EP (2) EP3489690A1 (enExample)
JP (2) JP2014529073A (enExample)
KR (1) KR20140074307A (enExample)
CN (2) CN106443011A (enExample)
AU (1) AU2012312907A1 (enExample)
BR (1) BR112014004389A2 (enExample)
CA (1) CA2846602A1 (enExample)
EA (1) EA201490384A1 (enExample)
ES (1) ES2721907T3 (enExample)
IN (1) IN2014MN00377A (enExample)
MX (1) MX346096B (enExample)
PL (1) PL2748605T3 (enExample)
PT (1) PT2748605T (enExample)
TR (1) TR201903235T4 (enExample)
WO (1) WO2013043310A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106370857A (zh) 2008-10-21 2017-02-01 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
CN102725636B (zh) 2009-12-20 2015-04-01 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
PT2748605T (pt) * 2011-08-26 2019-05-03 Astute Medical Inc Processos e composições para o diagnóstico e o prognóstico de lesões renais e de insuficiência renal
WO2013086359A1 (en) 2011-12-08 2013-06-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP6681195B2 (ja) 2013-01-17 2020-04-15 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
US11261257B2 (en) 2013-01-28 2022-03-01 Diasorin S.P.A. Methods for detecting 1,25-dihydroxyvitamin D and related antibodies
EP2759550B1 (en) 2013-01-28 2018-08-15 DiaSorin S.p.A. Method and kit for detecting 1,25-dihydroxyvitamin D and related antibodies
US10983136B2 (en) * 2013-01-28 2021-04-20 Diasorin S.P.A. Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker
CN110007084B (zh) 2013-12-03 2022-11-18 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
KR102431003B1 (ko) 2014-10-20 2022-08-09 아스튜트 메디컬 인코포레이티드 신손상 및 신부전의 진단 및 예후를 위한 방법 및 조성물
EP3245515A1 (en) * 2015-01-18 2017-11-22 DiaSorin S.p.A. Use of 1,25-dihydroxyvitamin d values in ratio with pth as a prognostic biomarker
US11243202B2 (en) 2015-04-09 2022-02-08 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN105466984B (zh) * 2016-01-14 2018-12-28 郑以山 用于肾脏非显性损伤的预警装置及其使用方法
CN109844526A (zh) 2016-06-06 2019-06-04 机敏医药股份有限公司 使用胰岛素样生长因子结合蛋白7和金属蛋白酶2的组织抑制剂管理急性肾损伤
MX2019008260A (es) 2017-01-12 2020-01-27 Astute Medical Inc Metodos y composiciones para la evaluacion y tratamiento de lesion renal e insuficiencia renal con base en la medicion del ligando 14 de quimiocina de la porcion c-c.
US11346846B2 (en) 2017-02-06 2022-05-31 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3606554A4 (en) 2017-04-05 2020-12-09 Astute Medical, Inc. ASSAYS FOR TIMP2 WITH IMPROVED EFFICIENCY IN BIOLOGICAL SAMPLES
CA3101470A1 (en) 2018-05-24 2019-11-28 Renibus Therapeutics, Inc. Methods of treating patients at risk for renal injury and renal failure
CN109251956A (zh) * 2018-09-18 2019-01-22 青岛大学 糖尿病大鼠胰岛内MyD88 mRNA表达及黄芪的调节作用
WO2020092909A1 (en) * 2018-11-02 2020-05-07 Prevencio, Inc. Prognostic and diagnostic methods for risk of acute kidney injury
CN114113575B (zh) * 2020-08-28 2023-06-02 菲鹏生物股份有限公司 标记复合物及其制备方法与应用
CN116434960B (zh) * 2023-06-13 2023-10-13 中国人民解放军总医院 一种心源性休克临床决策支持系统、设备及可存储介质
WO2025033619A1 (ko) * 2023-08-07 2025-02-13 경상국립대학교병원 신 대체요법 개시 결정을 위한 정보 제공 방법 및 이의 결정을 위한 말기 신질환 진단용 조성물

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
CA2072758A1 (en) 1990-09-14 1992-03-15 Kenneth Francis Buechler Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
CA2107899A1 (en) 1991-04-10 1992-10-11 Gunars Edwin Valkirs Novel conjugates and assays for simultaneous detection of multiple ligands
ATE177841T1 (de) 1991-04-10 1999-04-15 Biosite Diagnostics Inc ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
DK2360475T3 (da) * 2003-03-27 2020-01-06 Childrens Hospital Med Ct Fremgangsmåde og kit til detektion af tidlig indtræden af renal tubulær celleskade
CN1791797A (zh) * 2003-03-27 2006-06-21 儿童医院医疗中心 用于检测肾小管细胞损伤的早发的方法和试剂盒
US7560244B2 (en) * 2003-06-04 2009-07-14 Joslin Diabetes Center, Inc. Method of evaluating a subject for risk or predisposition of reduced renal function over time
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
US20060003345A1 (en) * 2004-06-30 2006-01-05 Pfizer Inc RNA bioassay
CN101557825A (zh) * 2005-08-19 2009-10-14 森托科尔公司 抗蛋白酶解的抗体制剂
WO2007144781A2 (en) * 2006-04-21 2007-12-21 Diagnotech Pty. Ltd. Diagnostic methods and kits utilizing antibodies for metalloproteases
EP2479570A3 (en) * 2007-03-26 2012-09-26 Novartis AG Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
WO2009062520A1 (en) 2007-11-15 2009-05-22 Bioporto Diagnostics A/S Diagnostic use of individual molecular forms of a biomarker
CN101960308B (zh) * 2008-02-29 2014-07-09 国立大学法人名古屋大学 急性肾损伤及预后推测用生物标记物以及其用途
BRPI0917711A2 (pt) * 2008-08-28 2017-06-20 Astute Medical Inc método para avaliar o estado renal em um paciente, e, uso de um ou mais marcadores de lesão renal
WO2010025434A1 (en) * 2008-08-29 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN106370857A (zh) * 2008-10-21 2017-02-01 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
JP5752600B2 (ja) * 2008-11-10 2015-07-22 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法
US9229010B2 (en) * 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BRPI0924639B1 (pt) * 2009-06-02 2021-12-07 Biocrates Life Sciences Ag Novos biomarcadores para avaliação de doenças renais
US8871459B2 (en) * 2009-08-07 2014-10-28 Astute Medical, Inc. Method for evaluating renal status by determining beta-2-glycoprotein 1
EA201290106A1 (ru) * 2009-09-18 2012-12-28 Астьют Медикал, Инк. Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности
MX2009012633A (es) * 2009-11-23 2011-05-24 Univ Mexico Nacional Autonoma Metodo de diagnostico para detectar la lesion renal aguda a traves del uso de la proteina de choque termico de 72 kda como un biomarcador sensible.
CN102725636B (zh) * 2009-12-20 2015-04-01 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
EP2539712A4 (en) 2010-02-26 2013-09-18 Astute Medical Inc METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
PT2748605T (pt) * 2011-08-26 2019-05-03 Astute Medical Inc Processos e composições para o diagnóstico e o prognóstico de lesões renais e de insuficiência renal

Similar Documents

Publication Publication Date Title
JP2013519095A5 (enExample)
JP2016505143A5 (enExample)
JP2013510321A5 (enExample)
JP2014521088A5 (enExample)
JP2013510322A5 (enExample)
JP2012517594A5 (enExample)
US20170199204A1 (en) Urine Biomarkers for Prediction of Recovery After Acute Kidney Injury: Proteomics
JP2013503344A5 (enExample)
JP2013531240A5 (enExample)
HRP20160733T1 (hr) Postupci i pripravci za postavljanje dijagnoze i prognoze ozljede bubrega i bubrežne insuficijencije
JP2013539861A5 (enExample)
JP2013515243A5 (enExample)
EP3208616A1 (en) Determination of neutrophil gelatinase-associated lipocalin (ngal) as a diagnostic marker for renal disorders
Rodrigues et al. Definitions, phenotypes, and subphenotypes in acute kidney injury—Moving towards precision medicine
TR201807542T4 (tr) Böbrek hasarı ve böbrek yetmezliği teşhisi ve prognozuna yönelik metotlar ve bileşimler.
JP2012517592A5 (enExample)
JP2013519866A5 (enExample)
MX2014002146A (es) Métodos y composiciones para diagnóstico y pronóstico de lesión renal e insuficiencia renal.
WO2013086359A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3004873A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3465201A1 (en) Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
JP2015129764A5 (enExample)
JP2013513086A5 (enExample)
WO2010093869A1 (en) Methods for monitoring allograft rejection
JP2015508181A5 (enExample)